TFA
VYGR icon

Toth Financial Advisory’s Voyager Therapeutics VYGR Stock Holding History

Toth Financial Advisory’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$875 Hold
250
– – ﹤0.01% 846
2026
Q1 		$965 Buy
+250
New +$984 ﹤0.01% 817

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Toth Financial Advisory's VYGR Position: Q2 2026 in Review

Toth Financial Advisory held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 250 shares worth $875. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Toth Financial Advisory first reported a position in VYGR in Q1 2026 and has held it in 2 quarters since. The position peaked at $965 in Q1 2026. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Toth Financial Advisory held 250 shares of Voyager Therapeutics worth $875 as of Q2 2026.
  • Toth Financial Advisory left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #846 holding.
  • Toth Financial Advisory first reported a position in Voyager Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Toth Financial Advisory's Voyager Therapeutics position peaked at $965 in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.